Glenmark Pharmaceuticals gets USFDA gesture for conventional antipsychotic drug Kumar Jeetendra | March 24, 2021 Drug firm Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US health regulator because of its generic phenothiazine antipsychotic Chlorpromazine Hydrochloride tablets. “The company has received approval from the United States Food and Drug Administration (USFDA) for Chlorpromazine Hydrochloride tablets USP, in the strengths of 10 mg, 25 mg, 50 mg, …
Johnson and Johnson says in talks with Indian government for preliminary of single-portion vaccine Kumar Jeetendra | April 9, 2021 Johnson & Johnson is in talks with India’s government to start a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The U.S. drugs and health care giant’s vaccine is currently approved for use in the USA, the European Union and other countries including Thailand and South Africa. The …
Caplin Point Laboratories arm gets USFDA gesture for Neostigmine Methylsulfate Injection Kumar Jeetendra | April 22, 2021 New Delhi: Caplin Point Laboratories on Thursday said its subsidiary has received approval from the US health regulator for Neostigmine Methylsulfate Injection. Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery. “Caplin Steriles Ltd (Caplin) has been granted final approval …
Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment Kumar Jeetendra | April 28, 2021 Mumbai, India; April 28, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied …
EMA opens audit of China’s Sinovac Covid jab Kumar Jeetendra | May 4, 2021 The European Medicines Agency said Tuesday it has started a “rolling review” of China’s Sinovac coronavirus jab, a process that could lead to eventual approval for the European market. Made by Sinovac’s Beijing-based Life Sciences unit, the vaccine contains an inactivated coronavirus that cannot cause a disease, but helps a person to develop antibodies against …
Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail used in the treatment of Covid-19 Kumar Jeetendra | May 5, 2021 Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 Casirivimab and Imdevimab is indicated for the treatment of mild to moderate Covid-19 in high-risk patients Partners with Cipla for pan-India distribution At a global level, Roche and its partner Regeneron are collaborating to …
Gland Pharma gets USFDA gesture for generic Foscarnet Sodium injection Kumar Jeetendra | May 15, 2021 New Delhi, Apr 22 (PTI) Drug firm Gland Pharma on Thursday said it has received approval from the US health regulator for its generic Foscarnet Sodium injection indicated for treatment of cytomegalovirus retinitis in patients with AIDS. The company has received “approval from the United States Food and Drug Administration (USFDA) for its Foscarnet Sodium …
Glenmark Pharma gets USFDA gesture for Icatibant Injection Kumar Jeetendra | May 25, 2021 Drug major Glenmark Pharma on Monday said it has received final approval from the US health regulator for Icatibant Injection, indicated for the treatment of acute attacks of hereditary angioedema (HAE). Hereditary angioedema (HAE) is a disorder that results in recurrent attacks of severe swelling. The approved product is a generic version of Firazyr Injection …
Glenmark Pharma gets last gesture from USFDA for Theophylline ER tablets Kumar Jeetendra | June 4, 2021 Glenmark Pharma on Friday said it has received final approval from the US health regulator for Theophylline extended-release (ER) tablets. Theophylline extended-release tablets are used to prevent and treat wheezing, shortness of breath, and chest tightness caused by asthma, chronic bronchitis, emphysema, and other lung diseases. In a regulatory filing Glenmark Pharmaceuticals said it has …
Cipla launches Spirofy®: Strengthens its lung leadership position by facilitating early diagnosis for COPD1 Kumar Jeetendra | November 17, 2021 Mumbai, India; November 17, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced the launch of Spirofy®, India’s first pneumotach based portable, wireless Spirometer, on World COPD Day. With this launch, the company intends to revolutionize Obstructive Airway Disease (OAD) diagnosis, in line with its ambition to strengthen its …
Optimum Flow Meter Accuracy Critical to Biofuel Production Kumar Jeetendra | November 17, 2021 As the UK hosts the UN Conference on Climate Change, Titan Enterprises determines it a fitting time to report on the success of its long-term OEM customer, Green Fuels Limited. With decarbonisation, circular economy and sustainability hitting the top of the agenda around the world, Green Fuels advances biofuel technologies and joint ventures to achieve …
DefiniGEN appoints Dr Chris Kirton as Chief Executive Officer Kumar Jeetendra | January 21, 2022 Cambridge, UK – 20th January 2022 – Life Science Newswire – DefiniGEN is pleased to announce the appointment of Dr Chris Kirton as Chief Executive Officer. Chris has more than 16 years of operational experience and joined DefiniGEN as Chief Operating Officer in June 2020. The appointment is key for DefiniGEN as they expand the …
